These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Ovize M; Baxter GF; Di Lisa F; Ferdinandy P; Garcia-Dorado D; Hausenloy DJ; Heusch G; Vinten-Johansen J; Yellon DM; Schulz R; Cardiovasc Res; 2010 Aug; 87(3):406-23. PubMed ID: 20448097 [TBL] [Abstract][Full Text] [Related]
11. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Heusch G Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517 [TBL] [Abstract][Full Text] [Related]
12. Past and present course of cardioprotection against ischemia-reperfusion injury. Liem DA; Honda HM; Zhang J; Woo D; Ping P J Appl Physiol (1985); 2007 Dec; 103(6):2129-36. PubMed ID: 17673563 [TBL] [Abstract][Full Text] [Related]
13. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury. Cao Z; Hu Y; Wu W; Ha T; Kelley J; Deng C; Chen Q; Li C; Li J; Li Y Cardiovasc Res; 2009 Dec; 84(3):442-51. PubMed ID: 19586942 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247 [TBL] [Abstract][Full Text] [Related]
16. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Hoke NN; Salloum FN; Kass DA; Das A; Kukreja RC Stem Cells; 2012 Feb; 30(2):326-35. PubMed ID: 22102597 [TBL] [Abstract][Full Text] [Related]
17. Effect of apelin-apelin receptor system in postischaemic myocardial protection: a pharmacological postconditioning tool? Rastaldo R; Cappello S; Folino A; Losano G Antioxid Redox Signal; 2011 Mar; 14(5):909-22. PubMed ID: 20615122 [TBL] [Abstract][Full Text] [Related]
18. Myocardial protection against reperfusion injury: the cGMP pathway. Garcia-Dorado D; Agulló L; Sartorio CL; Ruiz-Meana M Thromb Haemost; 2009 Apr; 101(4):635-42. PubMed ID: 19350105 [TBL] [Abstract][Full Text] [Related]
19. Regulation and actions of activin A and follistatin in myocardial ischaemia-reperfusion injury. Chen Y; Rothnie C; Spring D; Verrier E; Venardos K; Kaye D; Phillips DJ; Hedger MP; Smith JA Cytokine; 2014 Oct; 69(2):255-62. PubMed ID: 25052838 [TBL] [Abstract][Full Text] [Related]
20. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway. Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]